Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-androgenic pyrrolidines with tumor-inhibiting action

Anti-androgenic pyrrolidines with tumor-inhibiting action

US Patent 7138421 · Granted Nov 21, 2006

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer2024
Method and system for determining a carbohydrate intake event from glucose monit2024
Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer2022
Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibit2011
3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their2011
Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) recepto2011
Quinazoline derivatives, their preparation, their use, and medicaments comprisin2010
Anti-androgenic pyrrolidines with tumor-inhibiting action2009
Anti-androgenic pyrrolidines with tumor-inhibiting action2009
Anti-androgenic pyrrolidines with tumor-inhibiting action2009
Anti-androgenic pyrrolidines with tumor-inhibiting action2009
Anti-androgenic pyrrolidines with tumor-inhibiting action2009